BioCorRx Appoints Pharmaceutical & Finance Veteran Harsha Murthy to the Board of Directors Jan 24, 2023
BioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder Jan 19, 2023
